Company has an important 6 months ahead. If Andreas can hit his targets for 2023 they will be onboarding 60+ i-med sites and closing some of the opportunities in the pipeline.
- Forums
- ASX - By Stock
- 4DX
- Research
Research, page-1747
-
- There are more pages in this discussion • 993 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add 4DX (ASX) to my watchlist
|
|||||
Last
43.0¢ |
Change
-0.015(3.37%) |
Mkt cap ! $176.5M |
Open | High | Low | Value | Volume |
44.5¢ | 44.5¢ | 42.5¢ | $123.5K | 283.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 25367 | 43.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
43.5¢ | 6671 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 25367 | 0.430 |
7 | 23092 | 0.425 |
8 | 84701 | 0.420 |
5 | 20682 | 0.415 |
4 | 25673 | 0.410 |
Price($) | Vol. | No. |
---|---|---|
0.435 | 6671 | 3 |
0.440 | 9652 | 4 |
0.445 | 22499 | 10 |
0.450 | 92041 | 3 |
0.455 | 20614 | 2 |
Last trade - 14.47pm 13/08/2024 (20 minute delay) ? |
Featured News
4DX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online